HUMANIGEN
Humanigen is a biopharmaceutical company that uses its biologic capabilities and its proprietary platform technology to develop first-in-class human antibody therapeutics. It focuses on preventing the serious and potentially life-threatening side-effects associated with chimeric antigen receptor T-cell (CAR-T) therapy. Its pipeline includes programs such as Lenzilumab, Ifabotuzumab, and HGen005.
HUMANIGEN
Social Links:
Industry:
Biopharma Biotechnology Health Care Pharmaceutical
Founded:
2001-01-01
Address:
Burlingame, California, United States
Country:
United States
Website Url:
http://www.humanigen.com
Total Employee:
1+
Status:
Active
Contact:
650-243-3100
Email Addresses:
[email protected]
Total Funding:
369.45 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Content Delivery Network Google Universal Analytics Euro
Similar Organizations
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
AVEO Oncology
AVEO is a biopharmaceutical company that offers drug development strategies for targeted cancer therapeutics.
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Immutep
Immutep is a biopharmaceutical company developing immunotherapeutics in oncology.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Verastem Oncology
Verastem is a biopharmaceutical company that focuses on discovering and developing novel drugs that selectively target cancer stem cells.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Hercules Capital
Hercules Capital investment in Post-IPO Debt - Humanigen
Cheval Holdings
Cheval Holdings investment in Post-IPO Equity - Humanigen
Nomis Bay
Nomis Bay investment in Post-IPO Equity - Humanigen
Black Horse Capital Advisors
Black Horse Capital Advisors investment in Post-IPO Equity - Humanigen
Fidelity
Fidelity investment in Private Equity Round - Humanigen
Alloy Ventures
Alloy Ventures investment in Series D - Humanigen
Mitsubishi UFJ Capital
Mitsubishi UFJ Capital investment in Series D - Humanigen
Sofinnova Investments
Sofinnova Investments investment in Series D - Humanigen
5AM Ventures
5AM Ventures investment in Series D - Humanigen
GBS Ventures
GBS Ventures investment in Series D - Humanigen
Key Employee Changes
| Date | New article |
|---|---|
| 2021-06-07 | Humanigen Announces Ken Trbovich Appointed as Senior Vice President, Investor Relations |
Official Site Inspections
http://www.humanigen.com Semrush global rank: 1.13 M Semrush visits lastest month: 28.57 K
- Host name: 147.62.236.23.bc.googleusercontent.com
- IP address: 23.236.62.147
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Humanigen"
Humanigen - Crunchbase Company Profile & Funding
Humanigen is a biopharmaceutical company that uses its biologic capabilities and its proprietary platform technology to develop first-in-class human antibody therapeutics. It focuses on …See details»
Humanigen Inc. - Investor Relations
Jul 28, 2023 Humanigen, Inc. is a clinical stage biopharmaceutical company, developing a portfolio of proprietary immuno-oncology and immunolomodulatory antibodies. We are …See details»
Humanigen, Inc. - LinkedIn
Humanigen, Inc. (HGEN) is a clinical-stage biopharmaceutical company seeking to transform the treatment of cancers and infectious diseases, including COVID-19, by preventing and treating …See details»
SEC.gov | HOME
Dec 31, 2022 incorporation or organization) ... On March 30, 2023, Humanigen, Inc. (the “Company”) filed its Annual Report on Form 10-K for the year ended December 31, 2022, or …See details»
Humanigen Company Profile - Office Locations, Competitors
Jul 18, 2024 Humanigen (formerly known as KaloBios) is repositioning and developing its proprietary monoclonal antibodies to meet some critical unmet needs in cancer science. The …See details»
Humanigen Company Profile 2024: Valuation, Investors
Humanigen Inc is a biopharmaceutical company engaged in the development of proprietary monoclonal antibodies for various oncology indications and to enhance T-cell therapies, …See details»
Humanigen - The Org
Humanigen, Inc. (HGEN) is a clinical-stage biopharmaceutical company seeking to transform the treatment of cancers and infectious diseases, including COVID-19, by preventing and treating …See details»
Humanigen Inc Company Profile - Overview - GlobalData
Humanigen Inc (Humanigen) is a biopharmaceutical company that develops proprietary monoclonal antibodies for immunotherapy and oncology treatments.See details»
Company Humanigen, Inc. - MarketScreener.com
Jan 6, 2016 Humanigen, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing its portfolio of proprietary Humaneered anti-inflammatory immunology …See details»
Humanigen - Funding, Financials, Valuation & Investors
Humanigen is a biopharmaceutical company that focuses on developing human antibody therapeutics. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. ...See details»
Humanigen, Inc. (HGEN): history, ownership, mission, how it works ...
[relinking] Home History Owners Mission How It Works How It Makes Money A Brief History of Humanigen, Inc. (HGEN) Foundation and Early Years Humanigen, Inc. was founded in 2013 …See details»
Humanigen - Products, Competitors, Financials, Employees, …
Humanigen is a clinical-stage biopharmaceutical company focused on the treatment of cancers and infectious diseases, including COVID-19. It offers novel anti-human granulocyte …See details»
Humanigen Appoints Senior Executives to Management Team
Burlingame, CA, July 7, 2020 – Humanigen, Inc., (HGEN) (“Humanigen”), a clinical stage biopharmaceutical company focused on preventing and treating cytokine release syndrome …See details»
Humanigen Inc. - Financials - Annual Reports
At Humanigen Inc., we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by …See details»
Humanigen - Contacts, Employees, Board Members, Advisors
Organization. Humanigen . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. ... and Advisor Profiles 9. Contacts 5. About. Humanigen has 12 current …See details»
Humanigen Inc. - Humanigen and Chime Biologics Enter Into …
May 17, 2021 Humanigen, Inc. (Nasdaq:HGEN) (“Humanigen”), a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response …See details»
Humanigen - Overview, News & Similar companies | ZoomInfo.com
COVID-19 treatment developer Humanigen files for Chapter 11 bankruptcy - Yahoo News The Burlingame, California-based company, once controlled by convicted pharma executive Martin …See details»
Humanigen Announces Participation and Presentation at Multiple ...
Oct 4, 2021 Humanigen, Inc. (Nasdaq: HGEN) (“Humanigen”), a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response …See details»
US says former Humanigen chief scientific officer charged with …
Dec 23, 2024 An indictment unsealed on Monday charged the former chief scientific officer of biopharmaceutical company Humanigen with engaging in an insider trading scheme involving …See details»